Öner Doğan
Impact in
- Neurology top 10%
- Myasthenia Gravis and Thymoma
- Peripheral Neuropathies and Disorders
- CNS Lymphoma Diagnosis and Treatment
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 17
- Oncology 20
- Viral-associated cancers and disorders 5
- Cancer-related Molecular Pathways 5
- Co-authors
- Canan Alatlı (3 shared papers)Meliha Nalçacı (6 shared papers)Nesimi Bűyúkbabani (4 shared papers)Günçağ Dınçol (5 shared papers)Samuray Tuncer (2 shared papers)Nejat Dalay (2 shared papers)Mert Başaran (3 shared papers)Musa Altun (2 shared papers)
- Journals
- Blood (2 papers)International Journal of Cancer (2 papers)The Journal of Pediatrics (1 paper)Frontiers in Immunology (1 paper)Apmis (1 paper)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Öner Doğan
51 papers receiving 392 citations
Peers
Comparison fields: 5 of 55
- Neurology 118
- Pathology and Forensic Medicine 127
- Hematology 61
- Genetics 53
- Oncology 128
Countries citing papers authored by Öner Doğan
This map shows the geographic impact of Öner Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Öner Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Öner Doğan more than expected).
Fields of papers citing papers by Öner Doğan
This network shows the impact of papers produced by Öner Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Öner Doğan. The network helps show where Öner Doğan may publish in the future.
Co-authors
The 25 scholars most cited alongside Öner Doğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 40 | |
| 2 | 2016 | 33 | |
| 3 | 2014 | 33 | |
| 4 | 2002 | 24 | |
| 5 | 2000 | 24 | |
| 6 | P53 overexpression in nasopharyngeal carcinoma. | 2005 | 24 |
| 7 | 1997 | 19 | |
| 8 | 2020 | 15 | |
| 9 | 2002 | 13 | |
| 10 | 2011 | 11 | |
| 11 | 2011 | 10 | |
| 12 | 2003 | 10 | |
| 13 | 2007 | 9 | |
| 14 | 2013 | 9 | |
| 15 | 2000 | 9 | |
| 16 | 2018 | 8 | |
| 17 | 2003 | 8 | |
| 18 | 2010 | 7 | |
| 19 | 2011 | 7 | |
| 20 | 2010 | 6 |
About Öner Doğan
Öner Doğan is a scholar working on Pathology and Forensic Medicine, Oncology, Neurology, Genetics and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 404 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (7 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Hematological disorders and diagnostics (7 papers), Viral-associated cancers and disorders (5 papers), Cancer-related Molecular Pathways (5 papers), Acute Myeloid Leukemia Research (4 papers) and Antifungal resistance and susceptibility (4 papers). The work is most often cited by research in Neurology (118 citations), Pathology and Forensic Medicine (127 citations), Hematology (61 citations), Genetics (53 citations) and Oncology (128 citations). Öner Doğan has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Canan Alatlı, Meliha Nalçacı, Nesimi Bűyúkbabani, Günçağ Dınçol, Samuray Tuncer, Nejat Dalay, Mert Başaran, Musa Altun, Melih Aktan and İnci̇ Ayan. Their work appears in journals such as Blood, International Journal of Cancer, The Journal of Pediatrics, Frontiers in Immunology and Apmis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.